4 transcripts
NKTR
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
Executive Officer; Dr. Jonathan Zalevsky, our Chief Research and Development Officer; Dr. Mary Tagliaferri, our Chief Medical Officer; and Sandra Gardiner
NKTR
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
and Chief Executive Officer; Dr. Jonathan Zalevsky, our Chief Research and Development Officer; Dr. Mary Tagliaferri, our Chief Medical Officer
NKTR
Earnings call transcript
NASDAQ
2023 Q4
4 Mar 24
and CEO; Dr. Jonathan Zalevsky, our Chief of Research and Development; Dr. Mary Tagliaferri, our Chief Medical Officer; Sandra Gardiner, our Chief Financial
NKTR
Earnings call transcript
NASDAQ
2023 Q2
8 Aug 23
and CEO; Dr. Jonathan Zalevsky, our Chief of Research and Development; Dr. Mary Tagliaferri, our Chief Medical Officer; Jennifer Ruddock, our Chief
- Prev
- 1
- Next